MD
Income statement / Annual
Last year (2024), Pediatrix Medical Group, Inc.'s total revenue was $2.01 B,
an increase of 0.92% from the previous year.
In 2024, Pediatrix Medical Group, Inc.'s net income was -$99.07 M.
See Pediatrix Medical Group, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.01 B |
$1.99 B |
$1.97 B |
$1.91 B |
$1.73 B |
$1.78 B |
$3.65 B |
$3.46 B |
$3.18 B |
$2.78 B |
| Cost of Revenue |
$1.56 B
|
$1.57 B
|
$1.50 B
|
$1.40 B
|
$1.28 B
|
$1.28 B
|
$2.66 B
|
$2.46 B
|
$2.15 B
|
$1.85 B
|
| Gross Profit |
$454.34 M
|
$421.57 M
|
$467.03 M
|
$513.24 M
|
$449.32 M
|
$503.09 M
|
$989.51 M
|
$1.00 B
|
$1.03 B
|
$928.01 M
|
| Gross Profit Ratio |
0.23
|
0.21
|
0.24
|
0.27
|
0.26
|
0.28
|
0.27
|
0.29
|
0.32
|
0.33
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$238.44 M
|
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$244.51 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$238.44 M
|
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$244.51 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
| Other Expenses |
$284.62 M
|
$186.70 M
|
$62.95 M
|
$46.97 M
|
$102.24 M
|
$86.82 M
|
$111.28 M
|
$102.88 M
|
$89.26 M
|
$64.23 M
|
| Operating Expenses |
$523.06 M
|
$414.24 M
|
$294.35 M
|
$310.32 M
|
$351.19 M
|
$331.33 M
|
$543.66 M
|
$519.98 M
|
$461.84 M
|
$370.14 M
|
| Cost And Expenses |
$2.08 B
|
$1.99 B
|
$1.80 B
|
$1.71 B
|
$1.64 B
|
$1.61 B
|
$3.20 B
|
$2.98 B
|
$2.61 B
|
$2.22 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$40.74 M
|
$42.08 M
|
$39.70 M
|
$68.72 M
|
$110.48 M
|
$118.93 M
|
$92.95 M
|
$74.56 M
|
$63.09 M
|
$23.11 M
|
| Depreciation & Amortization |
$32.23 M
|
$36.17 M
|
$35.64 M
|
$32.15 M
|
$28.44 M
|
$25.93 M
|
$83.83 M
|
$102.88 M
|
$89.26 M
|
$64.23 M
|
| EBITDA |
-$28.37 M |
$29.89 M |
$156.70 M |
$236.10 M |
$146.07 M |
$203.64 M |
$527.69 M |
$587.86 M |
$660.95 M |
$622.10 M |
| EBITDA Ratio |
-0.01
|
0.01
|
0.08
|
0.12
|
0.08
|
0.11
|
0.14
|
0.17
|
0.21
|
0.22
|
| Operating Income Ratio |
-0.03
|
0
|
0.09
|
0.11
|
0.06
|
0.1
|
0.12
|
0.14
|
0.18
|
0.2
|
| Total Other Income/Expenses Net |
-$32.63 M
|
-$55.68 M
|
-$91.32 M
|
-$67.69 M
|
-$90.98 M
|
-$112.97 M
|
$120.45 M
|
-$69.65 M
|
-$57.89 M
|
-$18.14 M
|
| Income Before Tax |
-$101.34 M
|
-$48.36 M
|
$81.37 M
|
$135.23 M
|
$7.15 M
|
$58.78 M
|
$368.84 M
|
$410.42 M
|
$513.80 M
|
$539.73 M
|
| Income Before Tax Ratio |
-0.05
|
-0.02
|
0.04
|
0.07
|
0
|
0.03
|
0.1
|
0.12
|
0.16
|
0.19
|
| Income Tax Expense |
-$2.27 M
|
$12.05 M
|
$18.81 M
|
$27.24 M
|
$16.73 M
|
$16.58 M
|
$100.21 M
|
$90.05 M
|
$189.20 M
|
$204.04 M
|
| Net Income |
-$99.07 M
|
-$60.41 M
|
$66.34 M
|
$130.96 M
|
-$796.49 M
|
-$1.50 B
|
$268.63 M
|
$320.37 M
|
$324.91 M
|
$336.32 M
|
| Net Income Ratio |
-0.05
|
-0.03
|
0.03
|
0.07
|
-0.46
|
-0.84
|
0.07
|
0.09
|
0.1
|
0.12
|
| EPS |
-1.19 |
-0.72 |
0.8 |
1.52 |
-9.31 |
-17.78 |
2.95 |
3.42 |
3.47 |
3.59 |
| EPS Diluted |
-1.19 |
-0.73 |
0.79 |
1.52 |
-9.55 |
-17.94 |
2.93 |
3.42 |
3.47 |
3.58 |
| Weighted Average Shares Out |
$83.33 M
|
$84.02 M
|
$82.95 M
|
$86.42 M
|
$85.59 M
|
$84.25 M
|
$91.10 M
|
$92.43 M
|
$92.42 M
|
$93.74 M
|
| Weighted Average Shares Out Diluted |
$83.33 M
|
$82.20 M
|
$84.12 M
|
$86.42 M
|
$85.59 M
|
$84.25 M
|
$91.61 M
|
$93.72 M
|
$93.72 M
|
$93.96 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
